Known targets — ChEMBL curated mechanism
MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Erucic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 5/20 | 0.92 |
| ▸ | PPARD | Q03181 | 5/20 | 0.92 |
| ▸ | PPARA | Q07869 | 5/20 | 0.92 |
| ▸ | F7 | P08709 | 5/20 | 0.92 |
| ▸ | F3 | P13726 | 5/20 | 0.92 |
| ▸ | TERT | O14746 | 3/20 | 0.92 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.92 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.92 |
| ▸ | FABP4 | P15090 | 3/20 | 0.92 |
| ▸ | TOP1 | P11387 | 3/20 | 0.92 |
| ▸ | MAPT | P10636 | 2/20 | 0.92 |
| ▸ | BLM | P54132 | 2/20 | 0.92 |
| ▸ | LMNA | P02545 | 2/20 | 0.92 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.92 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.92 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.92 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.92 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.92 |
| ▸ | SIRT6 | Q8N6T7 | 2/20 | 0.92 |
| ▸ | PTPN7 | P35236 | 2/20 | 0.92 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oleic Acid SCHEMBL27890987 | 1.00 | PPARG (0.92) | PPARGPPARDPPARAF7F3 | |
| Oleic Acid SCHEMBL29601875 | 1.00 | PPARG (0.92) | PPARGPPARDPPARAF7F3 | |
| Nervonic Acid SCHEMBL27652694 | 1.00 | PPARG (0.92) | PPARGPPARDPPARAF7F3 | |
| Oleic Acid SCHEMBL27816432 | 1.00 | PPARG (0.92) | PPARGPPARDPPARAF7F3 | |
| Oleic Acid SCHEMBL3751821 | 1.00 | PPARG (0.92) | PPARGPPARDPPARAF7F3 | |
| Oleic Acid SCHEMBL8104041 | 0.98 | PPARG (0.89) | PPARGPPARDPPARAF7F3 | |
| Oleic Acid SCHEMBL28288665 | 0.98 | PPARG (0.89) | PPARGPPARDPPARAF7F3 | |
| Oleic Acid SCHEMBL28445727 | 0.98 | PPARG (0.89) | PPARGPPARDPPARAF7F3 | |
| Oleic Acid SCHEMBL11494840 | 0.98 | PPARG (0.89) | PPARGPPARDPPARAF7F3 | |
| Vaccenic Acid SCHEMBL25298899 | 0.96 | PPARG (1.00) | PPARGPPARDPPARAF7F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109844005-A | Bio-based polyelectrolyte complex compositions containing aliphatic compounds with increased hydrophobicity | 有机点击股份公司 | 2019-06-04 | — | — | CN | claimed |
| CN-106999396-A | Composition for strengthening hair fiber characteristic | 宝洁公司 | 2017-08-01 | — | — | CN | claimed |
| EP-0754031-B1 | MULTILAMELLAR DRUG DELIVERY SYSTEMS | SHIRE LAB INC (US) | 2004-03-24 | — | — | EP | claimed |
| EP-0754031-A4 | MULTILAMELLAR DRUG DELIVERY SYSTEMS | PHARMAVENE INC (US) | 2000-01-19 | — | — | EP | claimed |
| EP-0750494-A4 | HYDROPHOBIC DRUG DELIVERY SYSTEMS | PHARMAVENE INC (US) | 1998-05-20 | — | — | EP | claimed |
| EP-0840611-A1 | ORAL ACYCLOVIR DELIVERY | PHARMAVENE, INC. (US) | 1998-05-13 | — | — | EP | claimed |
| EP-0788346-A4 | EMULSIFIED DRUG DELIVERY SYSTEMS | PHARMAVENE INC (US) | 1998-05-06 | — | — | EP | claimed |
| EP-0788346-A1 | EMULSIFIED DRUG DELIVERY SYSTEMS | PHARMAVENE, INC. (US) | 1997-08-13 | — | — | EP | claimed |
| EP-0754031-A1 | MULTILAMELLAR DRUG DELIVERY SYSTEMS | PHARMAVENE, INC. (US) | 1997-01-22 | — | — | EP | claimed |
| EP-0750494-A1 | HYDROPHOBIC DRUG DELIVERY SYSTEMS | PHARMAVENE, INC. (US) | 1997-01-02 | — | — | EP | claimed |
| WO-1996040144-A1 | ORAL ACYCLOVIR DELIVERY | PHARMAVENE, INC. (US) | 1996-12-19 | — | — | WO | claimed |
| WO-1996037215-A1 | ORAL INSULIN DELIVERY | PHARMAVENE, INC. (US) | 1996-11-28 | — | — | WO | claimed |
| WO-1995027479-A1 | MULTILAMELLAR DRUG DELIVERY SYSTEMS | PHARMAVENE, INC. (US) | 1995-10-19 | — | — | WO | claimed |
| WO-1995025505-A1 | HYDROPHOBIC DRUG DELIVERY SYSTEMS | PHARMAVENE, INC. (US) | 1995-09-28 | — | — | WO | claimed |
| WO-1995025504-A1 | EMULSIFIED DRUG DELIVERY SYSTEMS | PHARMAVENE, INC. (US) | 1995-09-28 | — | — | WO | claimed |
| CN-116546890-A | Liquid composition comprising cereal beta-glucan or cereal extract containing beta-glucan | 西姆莱斯股份公司 | 2023-08-04 | — | — | CN | disclosed |
| CN-115701971-A | Method for producing personalized cosmetics | 巴斯夫欧洲公司 | 2023-02-14 | — | — | CN | disclosed |
| CN-106999396-A | Composition for strengthening hair fiber characteristic | 宝洁公司 | 2017-08-01 | — | — | CN | disclosed |
| CN-1289051-C | Compositions having enhanced deposition of a topically active compound on a surface | DIAL CORP (US) | 2006-12-13 | — | — | CN | disclosed |
| CN-1678288-A | Branched alcohol-based personal care compositions | PROCTER & GAMBLE (US) | 2005-10-05 | — | — | CN | disclosed |